• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用正电子发射断层扫描评估多发性硬化症患者的小胶质细胞激活情况。

Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.

作者信息

Airas Laura, Nylund Marjo, Rissanen Eero

机构信息

Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.

Turku PET Centre, Turku University Hospital and University of Turku, Turku, Finland.

出版信息

Front Neurol. 2018 Mar 26;9:181. doi: 10.3389/fneur.2018.00181. eCollection 2018.

DOI:10.3389/fneur.2018.00181
PMID:29632509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5879102/
Abstract

Understanding the mechanisms underlying progression in multiple sclerosis (MS) is one of the key elements contributing to the identification of appropriate therapeutic targets for this under-managed condition. In addition to plaque-related focal inflammatory pathology typical for relapsing remitting MS there are, in progressive MS, widespread diffuse alterations in brain areas outside the focal lesions. This diffuse pathology is tightly related to microglial activation and is co-localized with signs of neurodegeneration. Microglia are brain-resident cells of the innate immune system and overactivation of microglia is associated with several neurodegenerative diseases. Understanding the role of microglial activation in relation to developing neurodegeneration and disease progression may provide a key to developing therapies to target progressive MS. 18-kDa translocator protein (TSPO) is a mitochondrial molecule upregulated in microglia upon their activation. Positron emission tomography (PET) imaging using TSPO-binding radioligands provides a method to assess microglial activation in patients . In this , we summarize the current status of TSPO imaging in the field of MS. In addition, the review discusses new insights into the potential use of this method in treatment trials and in clinical assessment of progressive MS.

摘要

了解多发性硬化症(MS)进展的潜在机制是为这种治疗不足的疾病确定合适治疗靶点的关键因素之一。除了复发缓解型MS典型的与斑块相关的局灶性炎症病理外,在进展型MS中,局灶性病变以外的脑区还存在广泛的弥漫性改变。这种弥漫性病理与小胶质细胞活化密切相关,并与神经退行性变的迹象共定位。小胶质细胞是固有免疫系统中驻留在大脑中的细胞,小胶质细胞的过度活化与多种神经退行性疾病有关。了解小胶质细胞活化在神经退行性变发展和疾病进展中的作用可能为开发针对进展型MS的治疗方法提供关键。18 kDa转位蛋白(TSPO)是一种线粒体分子,在小胶质细胞活化时上调。使用TSPO结合放射性配体的正电子发射断层扫描(PET)成像提供了一种评估患者小胶质细胞活化的方法。在此,我们总结了MS领域中TSPO成像的现状。此外,本综述还讨论了该方法在治疗试验和进展型MS临床评估中的潜在应用的新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705b/5879102/0e9b165bb43e/fneur-09-00181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705b/5879102/0e9b165bb43e/fneur-09-00181-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/705b/5879102/0e9b165bb43e/fneur-09-00181-g001.jpg

相似文献

1
Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography.使用正电子发射断层扫描评估多发性硬化症患者的小胶质细胞激活情况。
Front Neurol. 2018 Mar 26;9:181. doi: 10.3389/fneur.2018.00181. eCollection 2018.
2
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.多发性硬化症患者使用连续 PET 成像评估芬戈莫德治疗对小胶质细胞激活的影响。
J Nucl Med. 2017 Oct;58(10):1646-1651. doi: 10.2967/jnumed.116.183020. Epub 2017 Mar 23.
3
Imaging neuroinflammation in multiple sclerosis using TSPO-PET.使用TSPO-PET成像技术观察多发性硬化症中的神经炎症
Clin Transl Imaging. 2015;3(6):461-473. doi: 10.1007/s40336-015-0147-6. Epub 2015 Oct 19.
4
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.用于TSPO的正电子发射断层显像(PET)放射性示踪剂的最新进展及其在神经成像中的应用。
Acta Pharm Sin B. 2021 Feb;11(2):373-393. doi: 10.1016/j.apsb.2020.08.006. Epub 2020 Aug 25.
5
Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis.多发性硬化症中 TSPO-PET 可测量的小胶质细胞激活的晚期预后指标。
Mult Scler Relat Disord. 2023 Jul;75:104755. doi: 10.1016/j.msard.2023.104755. Epub 2023 May 10.
6
Microglia in multiple sclerosis - pathogenesis and imaging.多发性硬化症中的小胶质细胞——发病机制与影像。
Curr Opin Neurol. 2022 Jun 1;35(3):299-306. doi: 10.1097/WCO.0000000000001045.
7
In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis.在体正电子发射断层显像(PET)成像显示,在多发性硬化症动物模型中,芬戈莫德治疗后小胶质细胞激活减少。
J Nucl Med. 2015 Feb;56(2):305-10. doi: 10.2967/jnumed.114.149955. Epub 2015 Jan 8.
8
TSPO PET with [F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.TSPO PET 联合 [F]GE-180 可敏感检测复发性缓解型多发性硬化患者的局灶性神经炎症。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1423-1431. doi: 10.1007/s00259-018-3974-7. Epub 2018 Mar 9.
9
In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.使用 PET 成像和放射性配体¹¹C-PK11195 体内检测继发性进展型多发性硬化的弥漫性炎症。
J Nucl Med. 2014 Jun;55(6):939-44. doi: 10.2967/jnumed.113.131698. Epub 2014 Apr 7.
10
Positron emission tomography imaging in evaluation of MS pathology in vivo.正电子发射断层扫描成像在活体评估多发性硬化症病理中的应用。
Mult Scler. 2018 Oct;24(11):1399-1412. doi: 10.1177/1352458518791680. Epub 2018 Aug 9.

引用本文的文献

1
Microglia positron emission tomography and progression in multiple sclerosis: thalamus on fire.小胶质细胞正电子发射断层扫描与多发性硬化症的进展:丘脑“着火”了。
Brain Commun. 2025 Apr 16;7(3):fcaf141. doi: 10.1093/braincomms/fcaf141. eCollection 2025.
2
Illusion of inactivity: Revisiting progressive multiple sclerosis treatment paradigms.静止错觉:重新审视进展性多发性硬化症的治疗模式。
Neural Regen Res. 2026 Mar 1;21(3):1134-1135. doi: 10.4103/NRR.NRR-D-24-01308. Epub 2025 Mar 25.
3
Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19.

本文引用的文献

1
Purinergic receptors P2Y12R and P2X7R: potential targets for PET imaging of microglia phenotypes in multiple sclerosis.嘌呤能受体 P2Y12R 和 P2X7R:多发性硬化症中小胶质细胞表型 PET 成像的潜在靶点。
J Neuroinflammation. 2017 Dec 22;14(1):259. doi: 10.1186/s12974-017-1034-z.
2
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia.调节巨噬细胞和小胶质细胞表型的分子机制
Front Immunol. 2017 Nov 10;8:1520. doi: 10.3389/fimmu.2017.01520. eCollection 2017.
3
TSPO imaging using the novel PET ligand [F]GE-180: quantification approaches in patients with multiple sclerosis.
小胶质细胞功能障碍、神经血管炎症和局灶性神经病理学与COVID-19中与白细胞介素-1和白细胞介素-6相关的全身炎症有关。
Nat Neurosci. 2025 Mar;28(3):558-576. doi: 10.1038/s41593-025-01871-z. Epub 2025 Mar 6.
4
TSPO-PET Reveals Higher Inflammation in White Matter Disrupted by Paramagnetic Rim Lesions in Multiple Sclerosis.TSPO-PET显示多发性硬化症中被顺磁边缘病变破坏的白质炎症更高。
bioRxiv. 2025 Jan 3:2025.01.03.627857. doi: 10.1101/2025.01.03.627857.
5
Advanced MRI Techniques: Diagnosis and Follow-Up of Multiple Sclerosis.先进的磁共振成像技术:多发性硬化症的诊断与随访
Diagnostics (Basel). 2024 May 28;14(11):1120. doi: 10.3390/diagnostics14111120.
6
Translocator Protein 18 kDa (TSPO): A Promising Molecular Target for Image-Guided Surgery of Solid Cancers.18 kDa转位蛋白(TSPO):实体癌图像引导手术中有前景的分子靶点。
Adv Pharm Bull. 2024 Mar;14(1):86-104. doi: 10.34172/apb.2024.015. Epub 2023 Oct 14.
7
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.多发性硬化症中的潜伏性病灶:小胶质细胞、淋巴细胞和病理生物化学机制。
Int J Mol Sci. 2023 Aug 10;24(16):12631. doi: 10.3390/ijms241612631.
8
Association of serum neurofilament light with microglial activation in multiple sclerosis.血清神经丝轻链与多发性硬化症中微胶质细胞激活的关联。
J Neurol Neurosurg Psychiatry. 2023 Sep;94(9):698-706. doi: 10.1136/jnnp-2023-331051. Epub 2023 May 2.
9
Positron Emission Tomography of Neuroimmune Responses in Humans: Insights and Intricacies.正电子发射断层扫描在人类神经免疫反应中的应用:观察与复杂性。
Semin Nucl Med. 2023 Mar;53(2):213-229. doi: 10.1053/j.semnuclmed.2022.08.008. Epub 2022 Oct 19.
10
Diagnosis and treatment of progressive multiple sclerosis: A position paper.进展性多发性硬化症的诊断和治疗:立场文件。
Eur J Neurol. 2023 Jan;30(1):9-21. doi: 10.1111/ene.15593. Epub 2022 Oct 25.
使用新型PET配体[F]GE-180的TSPO成像:多发性硬化症患者的定量方法
EJNMMI Res. 2017 Oct 26;7(1):89. doi: 10.1186/s13550-017-0340-x.
4
Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor.用于大麻素2型受体正电子发射断层显像的放射性配体。
J Labelled Comp Radiopharm. 2018 Mar;61(3):299-308. doi: 10.1002/jlcr.3579. Epub 2017 Dec 29.
5
Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.神经炎症及其与多发性硬化症脑容量变化和白质病变的关系。
Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.
6
Clinical trial design for progressive MS trials.进展性多发性硬化症临床试验设计。
Mult Scler. 2017 Oct;23(12):1642-1648. doi: 10.1177/1352458517729461.
7
Clinical outcome measures for progressive MS trials.进展性多发性硬化症临床试验的临床结局指标。
Mult Scler. 2017 Oct;23(12):1627-1635. doi: 10.1177/1352458517729465.
8
The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages.巨噬细胞标志物转位蛋白(TSPO)在促炎性“M1”型人类巨噬细胞上表达下调。
PLoS One. 2017 Oct 2;12(10):e0185767. doi: 10.1371/journal.pone.0185767. eCollection 2017.
9
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.那他珠单抗开始治疗后,在多发性硬化症病变中观察到PK11195摄取减少。
Mult Scler Relat Disord. 2017 Jul;15:27-33. doi: 10.1016/j.msard.2017.04.008. Epub 2017 Apr 29.
10
Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.原代小胶质细胞和巨噬细胞的促炎激活会增加啮齿动物而非人类中18 kDa转位蛋白的表达。
J Cereb Blood Flow Metab. 2017 Aug;37(8):2679-2690. doi: 10.1177/0271678X17710182. Epub 2017 May 22.